LTR Pharma (ASX:LTP) Accounts Payable: A$0.12 Mil (As of Dec. 2025)


ASX:LTP LTR Pharma Ltd ASX:LTP
15 GF Score
Price A$0.54
View Full Analysis

What is LTR Pharma Accounts Payable?

LTR Pharma ASX:LTP +0.93% 15 Accounts Payable is A$0.12 Mil as of Dec. 2025. GuruFocus rates ASX:LTP with a GF Score™ of 15/100.

LTR Pharma's Accounts Payable for the quarter that ended in Dec. 2025 was A$0.12 Mil.

LTR Pharma's quarterly Accounts Payable declined from Dec. 2024 (A$0.26 Mil) to Jun. 2025 (A$0.11 Mil) but then increased from Jun. 2025 (A$0.11 Mil) to Dec. 2025 (A$0.12 Mil).

LTR Pharma's annual Accounts Payable increased from Jun. 2023 (A$0.01 Mil) to Jun. 2024 (A$0.24 Mil) but then declined from Jun. 2024 (A$0.24 Mil) to Jun. 2025 (A$0.11 Mil).

LTR Pharma Accounts Payable Historical Data

* Premium members only.

The historical data trend for LTR Pharma's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

LTR Pharma Accounts Payable Chart

LTR Pharma Annual Data
Trend Jun21 Jun22 Jun23 Jun24 Jun25
Accounts Payable
0.00 0.47 0.01 0.24 0.11

LTR Pharma Semi-Annual Data
Jun21 Jun22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Accounts Payable Get a 7-Day Free Trial 0.21 0.24 0.26 0.11 0.12
ASX:LTP
15GF Score
LTR Pharma Ltd ASX:LTP
Accounts Payable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

LTR Pharma Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.

Frequently Asked Questions Learn more about Accounts Payable →
What does a Accounts Payable of A$0.12 Mil mean?
LTR Pharma (ASX:LTP) has a Accounts Payable of A$0.12 Mil as of Dec. 2025. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on LTR Pharma and its competitors.
Is LTR Pharma's Accounts Payable too high?
LTR Pharma's current Accounts Payable is A$0.12 Mil. Overall, LTR Pharma has a GF Score™ of 15/100, reflecting its overall financial health beyond just this single metric.
How does LTR Pharma's Accounts Payable compare to VRTX and REGN?
LTR Pharma's Accounts Payable of A$0.12 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Accounts Payable for a Biotechnology company?
A good Accounts Payable depends on the Biotechnology industry context. However, Accounts Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Accounts Payable mean?
A high Accounts Payable can signal that a stock is expensive relative to its fundamentals. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on LTR Pharma and its competitors. LTR Pharma's current Accounts Payable is A$0.12 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is LTR Pharma stock overvalued right now?
LTR Pharma (ASX:LTP) has a current Accounts Payable of A$0.12 Mil. The current Accounts Payable is A$0.12 Mil. LTR Pharma's overall GF Score™ is 15/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Accounts Payable calculated?
Accounts Payable is calculated from a company's financial statements. For LTR Pharma (ASX:LTP), the current Accounts Payable is A$0.12 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

LTR Pharma Business Description

Address 9A/204 Alice Street, Brisbane, QLD, AUS, 4000
LTR Pharma Ltd is a clinical stage pharmaceutical company focused on holistically improving men's health, physically and mentally, through the commercialization of an intranasal spray treatment for Erectile Dysfunction. SPONTAN is a Vardenafil-based nasal delivery formulation designed to be a lower dose fast-acting administration that provides a rapid and high availability to a patient's bloodstream compared with the incumbent oral ED treatment products on the market.
15GF Score

Get the complete analysis for ASX:LTP

Accounts Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

A$0.54
Price